Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2019

Open Access 01-12-2019 | Dyspnea | Study protocol

Effects of aerobic interval training on glucose tolerance in children and adolescents with cystic fibrosis: a randomized trial protocol

Authors: Karolinne Souza Monteiro, Matheus de Paiva Azevedo, Lucas Menescal Jales, Fernanda Elizabeth Pereira da Silva, Ricardo Fernando Arrais, Karla Morganna Pereira Pinto de Mendonça

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

Individuals with cystic fibrosis (CF) may develop CF-related diabetes (CFDR). This comorbidity is related to a poorer quality of life, microvascular complications, a decline in lung function, and an increase in exacerbations, as well as delayed growth and puberty. Evidence exists that physical exercise contributes to glycemic control in individuals with non-CF-related diabetes. This exercise is usually continuous with moderate intensity and long duration, which can cause muscle dyspnea and fatigue in CF individuals. Aerobic interval training (AIT) emerges as a safe and effective alternative for treating these individuals. The objective of this study is to evaluate the effects of AIT on glucose tolerance in children and adolescents with CF.

Methods

This study will be a two-arm, prospectively registered, randomized controlled trial with blind assessors and twenty 6- to 18-year-old individuals with cystic fibrosis (CF) from two different Brazilian states. People with CF will be randomly allocated to either the experimental or control group using block randomization, stratified by puberty stage,. Participants from both groups will receive an educational intervention and will be asked to continue their usual daily treatment for the full duration of the study. Those in the experimental group will perform AIT on a cycle ergometer at home three times a week, for 8 consecutive weeks. The sample characterization will include an assessment of puberty stage, socioeconomic status, dyspnea, and anthropometry. The primary outcome will be the change in glucose tolerance, while the secondary outcomes will include lung function, exercise tolerance, respiratory muscle strength, quality of life, and CF exacerbations. All outcomes will be assessed at baseline, week 9, and week 17.

Discussion

This is the first study to evaluate the effects of AIT on glucose tolerance in children and adolescents with CF. This study will serve as a basis for guiding clinical practice and decision-making in treating glucose intolerance and CF-related diabetes (CFRD) in children and adolescents with CF.

Trial registration

ClinicalTrials.gov Protocol Registration System: NCT03653949. Registered on August 31, 2018.
Appendix
Available only for authorised users
Literature
1.
2.
3.
4.
5.
Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, et al. International Committee on Mental Health in Cystic Fibrosis : Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71(1):26–34.PubMedCrossRef
6.
7.
8.
9.
10.
11.
Brennan AL, Beynon J. Clinical updates in cystic fibrosis-related diabetes. Semin Respir Crit Care Med. 2015;36(2):236–50.PubMedCrossRef
12.
13.
14.
15.
16.
Hebestreit H, Schmid K, Kieser S, Junge S, Ballmann M, Roth K, et al. Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulm Med. 2014;14(1):26.
17.
Savi D, Di Paolo M, Simmonds N, Onorati P, Internullo M, Quattrucci S, et al. Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis. BMC Pulm Med. 2015;15(1):2–9.CrossRef
18.
19.
20.
21.
22.
23.
24.
25.
Pandey A, Swift DL, Mcguire DK, Ayers CR, Neeland IJ, Blair SN, et al. Metabolic effects of exercise training among fitness- nonresponsive patients with type 2 diabetes: The HART-D study. Diabetes Care. 2015;38:1494–501.PubMedPubMedCentralCrossRef
26.
27.
28.
29.
Stevens D, Oades PJ, Williams CA. Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis. Eur J Pediatr. 2015;174(2):251–7.PubMedCrossRef
30.
Nguyen T, Pedder L, Timmons BW, Ploeger HE, Takken T, Obeid J. Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis. J Cyst Fibros. 2011;11(2):108–18.PubMedCrossRef
31.
32.
33.
34.
35.
36.
37.
38.
Alexander S, Alshafi K, Anderson A-K, Balfour-Lynn I, Bentley S, Buchdahl R, et al. Clinical Guidelines: Care of Children with Cystic Fibrosis [Internet]. Royal Brompton Hospital (7th edition) 2017. www.rbht.nhs.uk/childrencf (cited 07 february 2017). 2017. Available from: www.​rbht.​nhs.​uk/​childrencf
39.
40.
41.
42.
43.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:153–61.PubMedCrossRef
44.
Pereira CAC. Espirometria. J Bras Pneumol. 2002;28 suppl 3:S1–82.
45.
Mallozi MC. Valores de referência para espirometria em crianças e adolescentes, calculados a partir de uma amostra da cidade de São Paulo: Dissertation. São Paulo: Universidade Federal de São Paulo; 1995.
46.
Martins R, de Assumpção MS, Schivinski CIS. Perceived exertion and dyspnea in pediatrics: a review of rating scales. Med (ribeira Preto). 2014;47(1):25–35.CrossRef
47.
48.
49.
50.
Souza R. Pressões respiratórias estáticas máximas. J Bras Pneumol. 2002;28 Suppl 3:155–65.
51.
52.
53.
Rozov T, Cunha MT, Nascimento O, Quittner AL, Jardim JR. Linguistic validation of cystic fibrosis quality of life questionnaires. J Pediatr. 2006;82(2):151–6.CrossRef
54.
Cohen J. Statistical power analysis for the behavioral sciences. Vol. 2nd ed. Hillsdale: Lawrence Erlbaum; 1988.
55.
Francois ME, Little JP. The impact of acute high - intensity interval exercise on biomarkers of cardiovascular health in type 2 diabetes. Eur J Appl Physiol. 2017;117(8):1607–16.PubMedCrossRef
56.
Dela F, Ingersen A, Andersen N, Nielsen M, Petersen H, Hansen C, et al. Effects of one-legged high-intensity interval training on insulin-mediated skeletal muscle glucose homeostasis in patients with type 2 diabetes. Acta Physiol (Oxf). 2019;226(2):e13245. https://​doi.​org/​10.​1111/​apha.​13245.CrossRef
Metadata
Title
Effects of aerobic interval training on glucose tolerance in children and adolescents with cystic fibrosis: a randomized trial protocol
Authors
Karolinne Souza Monteiro
Matheus de Paiva Azevedo
Lucas Menescal Jales
Fernanda Elizabeth Pereira da Silva
Ricardo Fernando Arrais
Karla Morganna Pereira Pinto de Mendonça
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3803-8

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue

Study protocol

Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial

Study protocol

Collaborative care vs consultation liaison for depression and anxiety disorders in general practice: study protocol for two randomized controlled trials (the Danish Collabri Flex trials)

Study protocol

Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial

Study protocol

Partner-assisted cognitive behavioural therapy for insomnia versus cognitive behavioural therapy for insomnia: a randomised controlled trial

Study protocol

Growing Healthy Together: protocol for a randomized clinical trial using parent mentors for early childhood obesity intervention in a Latino community

Study protocol

A pragmatic pilot phase II randomised controlled trial of prothrombin complex concentrates (PCC) versus fresh frozen plasma (FFP) in adult patients who are undergoing heart surgery (PROPHESY)